J.Safra Asset Management Corp Gilead Sciences, Inc. Transaction History
J.Safra Asset Management Corp
- $1.54 Billion
- Q3 2025
A detailed history of J.Safra Asset Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, J.Safra Asset Management Corp holds 11 shares of GILD stock, worth $1,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 10
10.0%
Holding current value
$1,325
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,342Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.13 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.58 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.52 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $151B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...